...
首页> 外文期刊>Gastroenterology & Hepatology >The Use of Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
【24h】

The Use of Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma

机译:检查点抑制剂在肝细胞癌患者中的使用

获取原文

摘要

GAA? The liver is an important organ through which toxins and microbial products are eliminated. It is like an immunogenic machine. It has to be tolerant of the immune mobilization of the nearby gut and of exposure to all of the products that the body can encounter (eg, bacteria and food). Checkpoint inhibitors, which are critical immunotherapy players, can alter immune reactions in liver cancer cells in the liver or metastatic disease sites, and the immune system can, as such, fight off disease.
机译:GAA?肝脏是消除毒素和微生物产物的重要器官。它就像一个免疫原性的机器。它必须能容忍附近肠道的免疫动员,并能承受人体可能遇到的所有产品(例如细菌和食物)。检查点抑制剂是至关重要的免疫疗法,可以改变肝脏或转移性疾病部位中肝癌细胞的免疫反应,并且免疫系统可以抵抗疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号